MedPath

se of controlled heated intravesical chemotherapy in urinary bladder cancer

Not Applicable
Conditions
Health Condition 1: N329- Bladder disorder, unspecified
Registration Number
CTRI/2022/02/040185
Lead Sponsor
Rajiv Gandhi Cancer Institute and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Post-operative hyperthermic intravesical mitomycin will be given in all patients of non muscle invasive bladder cancer.

Exclusion Criteria

1. Patient having:

- gross hematuria

- bladder perforation

- muscle invasive disease

2. Patient not willing to sign consent for the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath